$67.5bn
$XX.Xbn
260k
292
$XX.Xbn
Despite the fluctuations in critical economic factors, including Medicare and Medicaid funding, the number of people with health insurance and per capita disposable income, specialty hospital revenue has grown at a CAGR of 2.9%. It is expected to total $67.5 billion in 2024 when revenue will inch up 0.2% in 2024 alone. Supportive investment income and diverse payor sources have contributed to continued revenue growth. And government funding during COVID-19 and the implementation of telehealth allowed the hospitals to weather the pandemic's demand and cost shocks.
Industry revenue has grown at a CAGR of 2.9 % over the past five years, to reach an estimated $67.5bn in 2024.
Market size is projected to grow over the next five years.
Company | Market Share (%)
2024 | Revenue ($m)
2024 | Profit ($m)
2024 | Profit Margin (%)
2024 |
---|---|---|---|---|
Memorial Sloan Kettering Cancer Center | 5,604.7 | 803.6 | 14.3 | |
Encompass Health Corporation | 4,909.3 | 604.1 | 12.3 | |
Select Medical Holdings Corp | 3,479.5 | 304.8 | 8.8 |
To view the market share and analysis for all 3 top companies in this industry, view purchase options.
Industry revenue is measured across several distinct product and services lines, including Cancer treatment, Long-term acute care and Diseases of the circulatory system. Cancer treatment is the largest segment of the Specialty Hospitals in the US.
Cancer and disease contribute to nearly half of revenue
This industry includes companies that provide diagnostic and medical treatment to inpatients with specific diseases or medical conditions. Specialty hospitals primarily provide long-term care for the chronically ill and offer rehabilitation, restorative and adjunctive services to physically challenged or disabled people. The industry excludes specialty units within general hospitals or psychiatric or substance-abuse hospitals.
Purchase this report to view all 3 major companies in this industry.
NAICS 62231 - Specialty Hospitals in the US
Get an indication of the industry's health through historical, current and forward-looking trends in the performance indicators that make or break businesses.
Consolidation affords enhanced bargaining power when negotiating with health insurers. Smaller specialty hospitals are disadvantaged compared to general hospitals in negotiat...
Learn about an industry's products and services, markets and trends in international trade.
Cancer treatment represents the most popular service in specialized hospitals. Hospitals specializing in patients, women’s, or children’s hospitals may also offer cancer trea...
Discover where business activity is most concentrated in an industry and the factors driving these trends to find opportunities and conduct regional benchmarking.
State Certificate of Need (CON) laws approve expenses and new hospital projects and can also stifle entry and expansion. The Southwest and West regions do not have CON laws a...
Get data and insights on what's driving competition in an industry and the challenges industry operators and new entrants may face, with analysis built around Porter's Five Forces framework.
As the rate of innovation takes off, competition will heat up and pressure smaller and specialty hospitals to adopt new technologies and techniques that larger general hospita...
Learn about the performance of the top companies in the industry.
Larger specialty hospitals have strong profit and revenue growth and these larger establishments continue to invest in state-of-the-art medical technology and infrastructure, ...
Understand the demographic, economic and regulatory factors that shape how businesses in an industry perform.
Relaxed telehealth restrictions will boost revenue. Broad markets will allow hospitals to spread technology costs over an expanded revenue base.
View average costs for industry operators and compare financial data against an industry's financial benchmarks over time.
Investment in new technology will reduce labor costs by making all employees more efficient and increase revenue through broadening markets.
Including values and annual change:
IBISWorld has been a leading provider of trusted industry research for over 50 years to the most successful companies worldwide. With offices in Australia, the United States, the United Kingdom, Germany and China, we are proud to have local teams of analysts that conduct research, data analysis and forecasting to produce data-driven industry reports.
Our analysts start with official, verified and publicly available sources of data to build the most accurate picture of each industry. Analysts then leverage their expertise and knowledge of the local markets to synthesize trends into digestible content for IBISWorld readers. Finally, each report is reviewed by one of IBISWorld’s editors, who provide quality assurance to ensure accuracy and readability.
IBISWorld relies on human-verified data and human-written analysis to compile each standard industry report. We do not use generative AI tools to write insights, although members can choose to leverage AI-based tools within the platform to generate additional analysis formats.
Each industry report incorporates data and research from government databases, industry-specific sources, industry contacts, and our own proprietary database of statistics and analysis to provide balanced, independent and accurate insights.
Key data sources in the US include:
Analysts also use industry specific sources to complement catch-all sources, although their perspective may focus on a particular organization or representative body, rather than a clear overview of all industry operations. However, when balanced against other perspectives, industry-specific sources provide insights into industry trends.
These sources include:
Finally, IBISWorld’s global data scientists maintain a proprietary database of macroeconomic and demand drivers, which our analysts use to help inform industry data and trends. They also maintain a database of statistics and analysis on thousands of industries, which has been built over our more than 50-year history and offers comprehensive insights into long-term trends.
IBISWorld’s analysts and data scientists use the sources above to create forecasts for our proprietary datasets and industry statistics. Depending on the dataset, they may use regression analysis, multivariate analysis, time-series analysis or exponential smoothing techniques to project future data for the industry or driver. Additionally, analysts will leverage their local knowledge of industry operating and regulatory conditions to impart their best judgment on the forecast model.
IBISWorld prides itself on being a trusted, independent source of data, with over 50 years of experience building and maintaining rich datasets and forecasting tools. We are proud to be the keystone source of industry information for thousands of companies across the world.
Learn more about our methodology and data sourcing on the Help Center.
Unlock comprehensive answers and precise data upon purchase. View purchase options.
The market size of the Specialty Hospitals in the US industry in United States is $67.5bn in 2024.
There are 292 businesses in the Specialty Hospitals in the US industry in United States, which has declined at a CAGR of 0.6 % between 2019 and 2024.
The market size of the Specialty Hospitals in the US industry in United States has been growing at a CAGR of 2.9 % between 2019 and 2024.
Over the next five years, the Specialty Hospitals in the US industry in United States is expected to grow.
The biggest companies operating in the Specialty Hospitals market in United States are Memorial Sloan Kettering Cancer Center, Encompass Health Corporation and Select Medical Holdings Corp
Cancer treatment and Long-term acute care are part of the Specialty Hospitals in the US industry.
The company holding the most market share in United States is Memorial Sloan Kettering Cancer Center.
The level of competition is moderate and steady in the Specialty Hospitals in the US industry in United States.